APO Research
Talk to an analyst

APO RESEARCH · REPORT

Emicizumab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Emicizumab Injection Market Analysis and Forecast 2026-2032

27 December 2025194 pages

Choose your research edition.

Industry ResearchEmicizumab Injection Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Emicizumab Injection Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Emicizumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Emicizumab Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Emicizumab Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Emicizumab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Emicizumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Emicizumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Emicizumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Emicizumab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Emicizumab Injection include Roche Pharma (Schweiz) AG and Chugai Pharmaceutical etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Emicizumab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Emicizumab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Emicizumab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Emicizumab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Emicizumab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Emicizumab Injection sales, projected growth trends, production technology, application and end-user industry.

Emicizumab Injection Segment by Company

Roche Pharma (Schweiz) AG

Chugai Pharmaceutical

Emicizumab Injection Segment by Type

60mg (0.4ml)/Bottle

30mg (1ml)/Bottle

150mg (1ml)/Bottle

105mg (0.7ml)/Bottle

Emicizumab Injection Segment by Application

Hospital

Clinic

Others

Emicizumab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emicizumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Emicizumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emicizumab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Emicizumab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Emicizumab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Emicizumab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Emicizumab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 60mg (0.4ml)/Bottle Major Manufacturers Table 3. 30mg (1ml)/Bottle Major Manufacturers Table 4. 150mg (1ml)/Bottle Major Manufacturers Table 5. 105mg (0.7ml)/Bottle Major Manufacturers Table 6. Global Emicizumab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Emicizumab Injection Industry Trends Table 11. Emicizumab Injection Industry Drivers Table 12. Emicizumab Injection Industry Opportunities and Challenges Table 13. Emicizumab Injection Industry Restraints Table 14. Global Emicizumab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Emicizumab Injection Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Emicizumab Injection Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Emicizumab Injection Revenue Market Share by Region (2021-2026) Table 18. Global Emicizumab Injection Revenue Market Share by Region (2027-2032) Table 19. Global Emicizumab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (L) Table 20. Global Emicizumab Injection Sales by Region (2021-2026) & (L) Table 21. Global Emicizumab Injection Sales by Region (2027-2032) & (L) Table 22. Global Emicizumab Injection Sales Market Share by Region (2021-2026) Table 23. Global Emicizumab Injection Sales Market Share by Region (2027-2032) Table 24. Global Emicizumab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Emicizumab Injection Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Emicizumab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Emicizumab Injection Sales Market Share by Manufacturers (2021-2026) Table 28. Global Emicizumab Injection Sales Price (US$/mL) of Manufacturers (2021-2026) Table 29. Global Emicizumab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Emicizumab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Emicizumab Injection Manufacturers, Product Type & Application Table 32. Global Emicizumab Injection Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Emicizumab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Emicizumab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Emicizumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Emicizumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Emicizumab Injection Revenue Market Share by Type (2021-2026) Table 39. Global Emicizumab Injection Revenue Market Share by Type (2027-2032) Table 40. Global Emicizumab Injection Sales by Type 2021 VS 2025 VS 2032 (L) Table 41. Global Emicizumab Injection Sales by Type (2021-2026) & (L) Table 42. Global Emicizumab Injection Sales by Type (2027-2032) & (L) Table 43. Global Emicizumab Injection Sales Market Share by Type (2021-2026) Table 44. Global Emicizumab Injection Sales Market Share by Type (2027-2032) Table 45. Global Emicizumab Injection Price by Type (2021-2026) & (US$/mL) Table 46. Global Emicizumab Injection Price by Type (2027-2032) & (US$/mL) Table 47. Global Emicizumab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Emicizumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Emicizumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Emicizumab Injection Revenue Market Share by Application (2021-2026) Table 51. Global Emicizumab Injection Revenue Market Share by Application (2027-2032) Table 52. Global Emicizumab Injection Sales by Application 2021 VS 2025 VS 2032 (L) Table 53. Global Emicizumab Injection Sales by Application (2021-2026) & (L) Table 54. Global Emicizumab Injection Sales by Application (2027-2032) & (L) Table 55. Global Emicizumab Injection Sales Market Share by Application (2021-2026) Table 56. Global Emicizumab Injection Sales Market Share by Application (2027-2032) Table 57. Global Emicizumab Injection Price by Application (2021-2026) & (US$/mL) Table 58. Global Emicizumab Injection Price by Application (2027-2032) & (US$/mL) Table 59. Roche Pharma (Schweiz) AG Company Information Table 60. Roche Pharma (Schweiz) AG Business Overview Table 61. Roche Pharma (Schweiz) AG Emicizumab Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 62. Roche Pharma (Schweiz) AG Emicizumab Injection Product Portfolio Table 63. Roche Pharma (Schweiz) AG Recent Development Table 64. Chugai Pharmaceutical Company Information Table 65. Chugai Pharmaceutical Business Overview Table 66. Chugai Pharmaceutical Emicizumab Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 67. Chugai Pharmaceutical Emicizumab Injection Product Portfolio Table 68. Chugai Pharmaceutical Recent Development Table 69. North America Emicizumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Emicizumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Emicizumab Injection Sales by Type (2021-2026) & (L) Table 72. North America Emicizumab Injection Sales by Type (2027-2032) & (L) Table 73. North America Emicizumab Injection Sales Price by Type (2021-2026) & (US$/mL) Table 74. North America Emicizumab Injection Sales Price by Type (2027-2032) & (US$/mL) Table 75. North America Emicizumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 76. North America Emicizumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 77. North America Emicizumab Injection Sales by Application (2021-2026) & (L) Table 78. North America Emicizumab Injection Sales by Application (2027-2032) & (L) Table 79. North America Emicizumab Injection Sales Price by Application (2021-2026) & (US$/mL) Table 80. North America Emicizumab Injection Sales Price by Application (2027-2032) & (US$/mL) Table 81. North America Emicizumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Emicizumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 83. North America Emicizumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 84. North America Emicizumab Injection Sales by Country (2021 VS 2025 VS 2032) & (L) Table 85. North America Emicizumab Injection Sales by Country (2021-2026) & (L) Table 86. North America Emicizumab Injection Sales by Country (2027-2032) & (L) Table 87. North America Emicizumab Injection Sales Price by Country (2021-2026) & (US$/mL) Table 88. North America Emicizumab Injection Sales Price by Country (2027-2032) & (US$/mL) Table 89. United States Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 90. Canada Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 91. Mexico Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 92. Europe Emicizumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Emicizumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Emicizumab Injection Sales by Type (2021-2026) & (L) Table 95. Europe Emicizumab Injection Sales by Type (2027-2032) & (L) Table 96. Europe Emicizumab Injection Sales Price by Type (2021-2026) & (US$/mL) Table 97. Europe Emicizumab Injection Sales Price by Type (2027-2032) & (US$/mL) Table 98. Europe Emicizumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Emicizumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Emicizumab Injection Sales by Application (2021-2026) & (L) Table 101. Europe Emicizumab Injection Sales by Application (2027-2032) & (L) Table 102. Europe Emicizumab Injection Sales Price by Application (2021-2026) & (US$/mL) Table 103. Europe Emicizumab Injection Sales Price by Application (2027-2032) & (US$/mL) Table 104. Europe Emicizumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Emicizumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. Europe Emicizumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. Europe Emicizumab Injection Sales by Country (2021 VS 2025 VS 2032) & (L) Table 108. Europe Emicizumab Injection Sales by Country (2021-2026) & (L) Table 109. Europe Emicizumab Injection Sales by Country (2027-2032) & (L) Table 110. Europe Emicizumab Injection Sales Price by Country (2021-2026) & (US$/mL) Table 111. Europe Emicizumab Injection Sales Price by Country (2027-2032) & (US$/mL) Table 112. Germany Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 113. France Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 114. U.K. Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 115. Italy Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 116. Russia Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 117. Spain Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 118. Netherlands Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 119. Switzerland Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 120. Sweden Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 121. Poland Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 122. China Emicizumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 123. China Emicizumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 124. China Emicizumab Injection Sales by Type (2021-2026) & (L) Table 125. China Emicizumab Injection Sales by Type (2027-2032) & (L) Table 126. China Emicizumab Injection Sales Price by Type (2021-2026) & (US$/mL) Table 127. China Emicizumab Injection Sales Price by Type (2027-2032) & (US$/mL) Table 128. China Emicizumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 129. China Emicizumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 130. China Emicizumab Injection Sales by Application (2021-2026) & (L) Table 131. China Emicizumab Injection Sales by Application (2027-2032) & (L) Table 132. China Emicizumab Injection Sales Price by Application (2021-2026) & (US$/mL) Table 133. China Emicizumab Injection Sales Price by Application (2027-2032) & (US$/mL) Table 134. Asia Emicizumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia Emicizumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia Emicizumab Injection Sales by Type (2021-2026) & (L) Table 137. Asia Emicizumab Injection Sales by Type (2027-2032) & (L) Table 138. Asia Emicizumab Injection Sales Price by Type (2021-2026) & (US$/mL) Table 139. Asia Emicizumab Injection Sales Price by Type (2027-2032) & (US$/mL) Table 140. Asia Emicizumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Emicizumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Emicizumab Injection Sales by Application (2021-2026) & (L) Table 143. Asia Emicizumab Injection Sales by Application (2027-2032) & (L) Table 144. Asia Emicizumab Injection Sales Price by Application (2021-2026) & (US$/mL) Table 145. Asia Emicizumab Injection Sales Price by Application (2027-2032) & (US$/mL) Table 146. Asia Emicizumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Emicizumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Asia Emicizumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Asia Emicizumab Injection Sales by Country (2021 VS 2025 VS 2032) & (L) Table 150. Asia Emicizumab Injection Sales by Country (2021-2026) & (L) Table 151. Asia Emicizumab Injection Sales by Country (2027-2032) & (L) Table 152. Asia Emicizumab Injection Sales Price by Country (2021-2026) & (US$/mL) Table 153. Asia Emicizumab Injection Sales Price by Country (2027-2032) & (US$/mL) Table 154. Japan Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 155. South Korea Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 156. India Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 157. Australia Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 158. Taiwan Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 159. Southeast Asia Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 160. SAMEA Emicizumab Injection Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Emicizumab Injection Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Emicizumab Injection Sales by Type (2021-2026) & (L) Table 163. SAMEA Emicizumab Injection Sales by Type (2027-2032) & (L) Table 164. SAMEA Emicizumab Injection Sales Price by Type (2021-2026) & (US$/mL) Table 165. SAMEA Emicizumab Injection Sales Price by Type (2027-2032) & (US$/mL) Table 166. SAMEA Emicizumab Injection Revenue by Application (2021-2026) & (US$ Million) Table 167. SAMEA Emicizumab Injection Revenue by Application (2027-2032) & (US$ Million) Table 168. SAMEA Emicizumab Injection Sales by Application (2021-2026) & (L) Table 169. SAMEA Emicizumab Injection Sales by Application (2027-2032) & (L) Table 170. SAMEA Emicizumab Injection Sales Price by Application (2021-2026) & (US$/mL) Table 171. SAMEA Emicizumab Injection Sales Price by Application (2027-2032) & (US$/mL) Table 172. SAMEA Emicizumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. SAMEA Emicizumab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. SAMEA Emicizumab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. SAMEA Emicizumab Injection Sales by Country (2021 VS 2025 VS 2032) & (L) Table 176. SAMEA Emicizumab Injection Sales by Country (2021-2026) & (L) Table 177. SAMEA Emicizumab Injection Sales by Country (2027-2032) & (L) Table 178. SAMEA Emicizumab Injection Sales Price by Country (2021-2026) & (US$/mL) Table 179. SAMEA Emicizumab Injection Sales Price by Country (2027-2032) & (US$/mL) Table 180. Brazil Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 181. Argentina Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 182. Chile Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 183. Colombia Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 184. Peru Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 185. Saudi Arabia Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 186. Israel Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 187. UAE Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 188. Turkey Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 189. Iran Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 190. Egypt Emicizumab Injection Revenue (2021-2032) & (US$ Million) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Emicizumab Injection Distributors List Table 194. Emicizumab Injection Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Emicizumab Injection Image Figure 2. Global Emicizumab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Emicizumab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 60mg (0.4ml)/Bottle Image Figure 5. 30mg (1ml)/Bottle Image Figure 6. 150mg (1ml)/Bottle Image Figure 7. 105mg (0.7ml)/Bottle Image Figure 8. Global Emicizumab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Emicizumab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Emicizumab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Emicizumab Injection Revenue (2021-2032) & (US$ Million) Figure 15. Global Emicizumab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Emicizumab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Emicizumab Injection Revenue Market Share by Region (2021-2032) Figure 18. Global Emicizumab Injection Sales (2021-2032) & (L) Figure 19. Global Emicizumab Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Figure 20. Global Emicizumab Injection Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Emicizumab Injection Sales YoY (2021-2032) & (L) Figure 22. Europe Emicizumab Injection Sales YoY (2021-2032) & (L) Figure 23. China Emicizumab Injection Sales YoY (2021-2032) & (L) Figure 24. Asia (Excluding China) Emicizumab Injection Sales YoY (2021-2032) & (L) Figure 25. South America, Middle East and Africa Emicizumab Injection Sales YoY (2021-2032) & (L) Figure 26. Global Emicizumab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Emicizumab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Emicizumab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Emicizumab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Emicizumab Injection Revenue Market Share by Type (2021-2032) Figure 32. Global Emicizumab Injection Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 33. Global Emicizumab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Emicizumab Injection Sales Market Share by Type (2021-2032) Figure 35. Global Emicizumab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Emicizumab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Emicizumab Injection Revenue Market Share by Application (2021-2032) Figure 38. Global Emicizumab Injection Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 39. Global Emicizumab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Emicizumab Injection Sales Market Share by Application (2021-2032) Figure 41. North America Emicizumab Injection Revenue Share by Type (2021-2032) Figure 42. North America Emicizumab Injection Sales Share by Type (2021-2032) Figure 43. North America Emicizumab Injection Revenue Share by Application (2021-2032) Figure 44. North America Emicizumab Injection Sales Share by Application (2021-2032) Figure 45. North America Emicizumab Injection Revenue Share by Country (2021-2032) Figure 46. North America Emicizumab Injection Sales Share by Country (2021-2032) Figure 47. Europe Emicizumab Injection Revenue Share by Type (2021-2032) Figure 48. Europe Emicizumab Injection Sales Share by Type (2021-2032) Figure 49. Europe Emicizumab Injection Revenue Share by Application (2021-2032) Figure 50. Europe Emicizumab Injection Sales Share by Application (2021-2032) Figure 51. Europe Emicizumab Injection Revenue Share by Country (2021-2032) Figure 52. Europe Emicizumab Injection Sales Share by Country (2021-2032) Figure 53. China Emicizumab Injection Revenue Share by Type (2021-2032) Figure 54. China Emicizumab Injection Sales Share by Type (2021-2032) Figure 55. China Emicizumab Injection Revenue Share by Application (2021-2032) Figure 56. China Emicizumab Injection Sales Share by Application (2021-2032) Figure 57. Asia Emicizumab Injection Revenue Share by Type (2021-2032) Figure 58. Asia Emicizumab Injection Sales Share by Type (2021-2032) Figure 59. Asia Emicizumab Injection Revenue Share by Application (2021-2032) Figure 60. Asia Emicizumab Injection Sales Share by Application (2021-2032) Figure 61. Asia Emicizumab Injection Revenue Share by Country (2021-2032) Figure 62. Asia Emicizumab Injection Sales Share by Country (2021-2032) Figure 63. SAMEA Emicizumab Injection Revenue Share by Type (2021-2032) Figure 64. SAMEA Emicizumab Injection Sales Share by Type (2021-2032) Figure 65. SAMEA Emicizumab Injection Revenue Share by Application (2021-2032) Figure 66. SAMEA Emicizumab Injection Sales Share by Application (2021-2032) Figure 67. SAMEA Emicizumab Injection Revenue Share by Country (2021-2032) Figure 68. SAMEA Emicizumab Injection Sales Share by Country (2021-2032) Figure 69. Emicizumab Injection Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Emicizumab Injection Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 60mg (0.4ml)/Bottle
  • 30mg (1ml)/Bottle
  • 150mg (1ml)/Bottle
  • 105mg (0.7ml)/Bottle
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Roche Pharma (Schweiz) AG
  • Chugai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Emicizumab Injection Market by Type
  3. 1.2.1 Global Emicizumab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 60mg (0.4ml)/Bottle
  5. 1.2.3 30mg (1ml)/Bottle
  6. 1.2.4 150mg (1ml)/Bottle
  7. 1.2.5 105mg (0.7ml)/Bottle
  8. 1.3 Emicizumab Injection Market by Application
  9. 1.3.1 Global Emicizumab Injection Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Emicizumab Injection Market Dynamics
  1. 2.1 Emicizumab Injection Industry Trends
  2. 2.2 Emicizumab Injection Industry Drivers
  3. 2.3 Emicizumab Injection Industry Opportunities and Challenges
  4. 2.4 Emicizumab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Emicizumab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Emicizumab Injection Revenue by Region
  3. 3.2.1 Global Emicizumab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Emicizumab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Emicizumab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Emicizumab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Emicizumab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Emicizumab Injection Sales by Region
  9. 3.4.1 Global Emicizumab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Emicizumab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Emicizumab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Emicizumab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Emicizumab Injection Revenue by Manufacturers
  2. 4.1.1 Global Emicizumab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Emicizumab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Emicizumab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Emicizumab Injection Sales by Manufacturers
  6. 4.2.1 Global Emicizumab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Emicizumab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Emicizumab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Emicizumab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Emicizumab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Emicizumab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Emicizumab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Emicizumab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Emicizumab Injection Market CR5 and HHI
  16. 4.8.2 2025 Emicizumab Injection Tier 1, Tier 2, and Tier 3
5 Emicizumab Injection Market by Type
  1. 5.1 Global Emicizumab Injection Revenue by Type
  2. 5.1.1 Global Emicizumab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Emicizumab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Emicizumab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Emicizumab Injection Sales by Type
  6. 5.2.1 Global Emicizumab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Emicizumab Injection Sales by Type (2021-2032) & (L)
  8. 5.2.3 Global Emicizumab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Emicizumab Injection Price by Type
6 Emicizumab Injection Market by Application
  1. 6.1 Global Emicizumab Injection Revenue by Application
  2. 6.1.1 Global Emicizumab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Emicizumab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Emicizumab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Emicizumab Injection Sales by Application
  6. 6.2.1 Global Emicizumab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Emicizumab Injection Sales by Application (2021-2032) & (L)
  8. 6.2.3 Global Emicizumab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Emicizumab Injection Price by Application
7 Company Profiles
  1. 7.1 Roche Pharma (Schweiz) AG
  2. 7.1.1 Roche Pharma (Schweiz) AG Company Information
  3. 7.1.2 Roche Pharma (Schweiz) AG Business Overview
  4. 7.1.3 Roche Pharma (Schweiz) AG Emicizumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Roche Pharma (Schweiz) AG Emicizumab Injection Product Portfolio
  6. 7.1.5 Roche Pharma (Schweiz) AG Recent Developments
  7. 7.2 Chugai Pharmaceutical
  8. 7.2.1 Chugai Pharmaceutical Company Information
  9. 7.2.2 Chugai Pharmaceutical Business Overview
  10. 7.2.3 Chugai Pharmaceutical Emicizumab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Chugai Pharmaceutical Emicizumab Injection Product Portfolio
  12. 7.2.5 Chugai Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Emicizumab Injection Market Size by Type
  2. 8.1.1 North America Emicizumab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Emicizumab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Emicizumab Injection Price by Type (2021-2032)
  5. 8.2 North America Emicizumab Injection Market Size by Application
  6. 8.2.1 North America Emicizumab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Emicizumab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Emicizumab Injection Price by Application (2021-2032)
  9. 8.3 North America Emicizumab Injection Market Size by Country
  10. 8.3.1 North America Emicizumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Emicizumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Emicizumab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Emicizumab Injection Market Size by Type
  2. 9.1.1 Europe Emicizumab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Emicizumab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Emicizumab Injection Price by Type (2021-2032)
  5. 9.2 Europe Emicizumab Injection Market Size by Application
  6. 9.2.1 Europe Emicizumab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Emicizumab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Emicizumab Injection Price by Application (2021-2032)
  9. 9.3 Europe Emicizumab Injection Market Size by Country
  10. 9.3.1 Europe Emicizumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Emicizumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Emicizumab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Emicizumab Injection Market Size by Type
  2. 10.1.1 China Emicizumab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Emicizumab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Emicizumab Injection Price by Type (2021-2032)
  5. 10.2 China Emicizumab Injection Market Size by Application
  6. 10.2.1 China Emicizumab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Emicizumab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Emicizumab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Emicizumab Injection Market Size by Type
  2. 11.1.1 Asia Emicizumab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Emicizumab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Emicizumab Injection Price by Type (2021-2032)
  5. 11.2 Asia Emicizumab Injection Market Size by Application
  6. 11.2.1 Asia Emicizumab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Emicizumab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Emicizumab Injection Price by Application (2021-2032)
  9. 11.3 Asia Emicizumab Injection Market Size by Country
  10. 11.3.1 Asia Emicizumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Emicizumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Emicizumab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Emicizumab Injection Market Size by Type
  2. 12.1.1 SAMEA Emicizumab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Emicizumab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Emicizumab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Emicizumab Injection Market Size by Application
  6. 12.2.1 SAMEA Emicizumab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Emicizumab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Emicizumab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Emicizumab Injection Market Size by Country
  10. 12.3.1 SAMEA Emicizumab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Emicizumab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Emicizumab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Emicizumab Injection Value Chain Analysis
  2. 13.1.1 Emicizumab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Emicizumab Injection Production Mode & Process
  6. 13.2 Emicizumab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Emicizumab Injection Distributors
  9. 13.2.3 Emicizumab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst